rs104894756
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000054.7(AVPR2):c.410G>A(p.Arg137His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000918 in 1,089,335 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 26)
Exomes 𝑓: 9.2e-7 ( 0 hom. 0 hem. )
Consequence
AVPR2
NM_000054.7 missense
NM_000054.7 missense
Scores
14
2
1
Clinical Significance
Conservation
PhyloP100: 8.03
Genes affected
AVPR2 (HGNC:897): (arginine vasopressin receptor 2) This gene encodes the vasopressin receptor, type 2, also known as the V2 receptor, which belongs to the seven-transmembrane-domain G protein-coupled receptor (GPCR) superfamily, and couples to Gs thus stimulating adenylate cyclase. The subfamily that includes the V2 receptor, the V1a and V1b vasopressin receptors, the oxytocin receptor, and isotocin and mesotocin receptors in non-mammals, is well conserved, though several members signal via other G proteins. All bind similar cyclic nonapeptide hormones. The V2 receptor is expressed in the kidney tubule, predominantly in the distal convoluted tubule and collecting ducts, where its primary property is to respond to the pituitary hormone arginine vasopressin (AVP) by stimulating mechanisms that concentrate the urine and maintain water homeostasis in the organism. When the function of this gene is lost, the disease Nephrogenic Diabetes Insipidus (NDI) results. The V2 receptor is also expressed outside the kidney although its tissue localization is uncertain. When these 'extrarenal receptors' are stimulated by infusion of a V2 selective agonist (dDAVP), a variety of clotting factors are released into the bloodstream. The physiologic importance of this property is not known - its absence does not appear to be detrimental in NDI patients. The gene expression has also been described in fetal lung tissue and lung cancer associated with alternative splicing. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.992
PP5
Variant X-153905916-G-A is Pathogenic according to our data. Variant chrX-153905916-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 10849.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-153905916-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AVPR2 | NM_000054.7 | c.410G>A | p.Arg137His | missense_variant | 3/4 | ENST00000646375.2 | NP_000045.1 | |
AVPR2 | NM_001146151.3 | c.410G>A | p.Arg137His | missense_variant | 3/3 | NP_001139623.1 | ||
AVPR2 | NR_027419.2 | n.466-103G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AVPR2 | ENST00000646375.2 | c.410G>A | p.Arg137His | missense_variant | 3/4 | NM_000054.7 | ENSP00000496396.1 | |||
ENSG00000284987 | ENST00000646191.1 | n.96+3154C>T | intron_variant | ENSP00000493873.1 |
Frequencies
GnomAD3 genomes Cov.: 26
GnomAD3 genomes
Cov.:
26
GnomAD3 exomes AF: 0.00000567 AC: 1AN: 176496Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 65290
GnomAD3 exomes
AF:
AC:
1
AN:
176496
Hom.:
AF XY:
AC XY:
0
AN XY:
65290
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 9.18e-7 AC: 1AN: 1089335Hom.: 0 Cov.: 36 AF XY: 0.00 AC XY: 0AN XY: 360545
GnomAD4 exome
AF:
AC:
1
AN:
1089335
Hom.:
Cov.:
36
AF XY:
AC XY:
0
AN XY:
360545
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 26
GnomAD4 genome
Cov.:
26
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 25, 2022 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 20159941, 10644689, 27649563, 22654789, 11920339, 19179480, 9826914, 7920187, 27355191, 15872203, 16319185, 11134505, 15166253, 9711877, 34020960, 8514744, 8104196, 21183406, 16845277, 10373137, 24030030, 9402099, 10820168, 9452109, 17020465, 8037205) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 12, 2024 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 137 of the AVPR2 protein (p.Arg137His). This variant is present in population databases (rs104894756, gnomAD 0.001%). This missense change has been observed in individuals with nephrogenic diabetes insipidus (PMID: 8104196, 9711877, 10820168). ClinVar contains an entry for this variant (Variation ID: 10849). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt AVPR2 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects AVPR2 function (PMID: 9711877, 27355191). For these reasons, this variant has been classified as Pathogenic. - |
Diabetes insipidus, nephrogenic, X-linked Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 05, 2005 | - - |
Nephrogenic syndrome of inappropriate antidiuresis Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 05, 2005 | - - |
Nephrogenic diabetes insipidus Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 31, 2022 | Variant summary: AVPR2 c.410G>A (p.Arg137His) results in a non-conservative amino acid change located in the GPCR, rhodopsin-like, 7TM domain (IPR017452) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.7e-06 in 176496 control chromosomes. c.410G>A has been reported in the literature in multiple individuals affected with Nephrogenic Diabetes Insipidus (example, Shoji_1998, Bichet_1993, Bichet_1994, Carroll_2006, Arthus_2000, Ashton_2018). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in the mutant receptor showing normal binding properties, but unable to stimulate the GS/adenylyl cyclase system (Barak_2001). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Pathogenic
D;D;.;D;.
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
.;.;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
H;H;.;H;H
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
.;D;D;D;D
REVEL
Pathogenic
Sift
Pathogenic
.;D;D;D;D
Sift4G
Pathogenic
.;D;D;D;D
Polyphen
D;D;.;D;D
Vest4
0.99, 0.97
MutPred
Loss of MoRF binding (P = 0.0457);Loss of MoRF binding (P = 0.0457);Loss of MoRF binding (P = 0.0457);Loss of MoRF binding (P = 0.0457);Loss of MoRF binding (P = 0.0457);
MVP
1.0
MPC
1.6
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at